B cell receptor-associated protein 31 levels in serum-derived extracellular vesicles are associated with therapeutic response and prognosis in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a multicenter study

Takanori Suzuki, Kentaro Matsuura, Yutaka Hashimoto, Masako Okina, Ryo Sato, Hayato Kawamura, Kiyoto Narita, Kei Fujiwara, Satoshi Narahara, Haruki Uojima, Hiromi Kataoka, Yasuhito Tanaka

Open source

DOI: 10.1007/s00535-026-02515-0
Published: 2026-09-04
Container: Journal of Gastroenterology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00535-026-02515-0,
  title = {B cell receptor-associated protein 31 levels in serum-derived extracellular vesicles are associated with therapeutic response and prognosis in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a multicenter study},
  author = {Takanori Suzuki and Kentaro Matsuura and Yutaka Hashimoto and Masako Okina and Ryo Sato and Hayato Kawamura and Kiyoto Narita and Kei Fujiwara and Satoshi Narahara and Haruki Uojima and Hiromi Kataoka and Yasuhito Tanaka},
  year = {2026},
  journal = {Journal of Gastroenterology},
  doi = {10.1007/s00535-026-02515-0},
  url = {https://doi.org/10.1007/s00535-026-02515-0}
}

RIS

TY  - JOUR
TI  - B cell receptor-associated protein 31 levels in serum-derived extracellular vesicles are associated with therapeutic response and prognosis in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a multicenter study
AU  - Takanori Suzuki
AU  - Kentaro Matsuura
AU  - Yutaka Hashimoto
AU  - Masako Okina
AU  - Ryo Sato
AU  - Hayato Kawamura
AU  - Kiyoto Narita
AU  - Kei Fujiwara
AU  - Satoshi Narahara
AU  - Haruki Uojima
AU  - Hiromi Kataoka
AU  - Yasuhito Tanaka
PY  - 2026
JO  - Journal of Gastroenterology
DO  - 10.1007/s00535-026-02515-0
UR  - https://doi.org/10.1007/s00535-026-02515-0
ER  -

APA

Suzuki, T., Matsuura, K., Hashimoto, Y., Okina, M., Sato, R., Kawamura, H., Narita, K., Fujiwara, K., Narahara, S., Uojima, H., Kataoka, H., & Tanaka, Y. (2026). B cell receptor-associated protein 31 levels in serum-derived extracellular vesicles are associated with therapeutic response and prognosis in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a multicenter study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02515-0

Source records

crossref · retrieved 2026-09-25T05:21:53.386Z